Switching from Wellbutrin SR to XL
When switching from Wellbutrin SR (sustained-release) to XL (extended-release), maintain the same total daily dose while changing from twice-daily to once-daily morning administration. 1, 2
Dosing Conversion Protocol
The conversion process should follow these steps:
Determine current total daily dose of Wellbutrin SR
- SR is typically taken twice daily (100-150 mg BID) 1
- Calculate the sum of both daily doses
Convert to equivalent XL dose
- Administer the same total daily dose as a single morning dose 2
- For example:
- 150 mg SR twice daily (300 mg total) → 300 mg XL once daily
- 100 mg SR twice daily (200 mg total) → 200 mg XL once daily (or nearest available dose)
Timing of administration
Important Clinical Considerations
Bioequivalence: All three formulations (IR, SR, and XL) are bioequivalent in terms of systemic exposure to bupropion 3
Pharmacokinetic differences:
Advantages of XL formulation:
Swallowing instructions:
- XL tablets must be swallowed whole
- Do not crush, divide, or chew the tablets 2
Monitoring After Switching
Efficacy: Assess therapeutic response after 1-2 weeks
- Once-daily dosing appears to be at least as effective as twice-daily dosing 5
Side effects: Monitor for:
Special Populations
Hepatic impairment:
- Moderate to severe impairment: Maximum 150 mg every other day
- Mild impairment: Consider reducing dose/frequency 2
Renal impairment:
- Consider reducing dose/frequency in patients with GFR <90 mL/min 2
Common Pitfalls to Avoid
Abrupt discontinuation: When discontinuing treatment with bupropion XL 300 mg daily, decrease to 150 mg once daily prior to full discontinuation 2
Seizure risk: Increase dose gradually to minimize seizure risk 2
Drug interactions:
Timing errors: Taking XL formulation late in the day can increase insomnia risk 1